HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 3,901-3,912 of 7,264
Drug study icon
CompletedEUCTR 2019-002992-33

A Randomized, Open-label, Rater-Blinded, Active-Controlled, International, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Flexibly Dosed Esketamine Nasal Spray Compared Wit...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
DepressionHistorical research record
Countries
France, Belgium, Austria, + 11 others
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedEUCTR 2006-001529-24

Adults adminstered Venlafaxine and Eszopiclone Response to Treatment (AVERT): A 31-Week, Efficacy, Safety and Tolerability Study of Eszopiclone 3 mg Co-administered with Venlafaxine in Subjects wit...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
DepressionHistorical research record
Countries
France, United Kingdom, Austria, + 2 others
Sponsor
Sepracor NV in care of Sepracor Inc.
Drug study icon
CompletedEUCTR 2007-003159-36

An eight-week, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of saredutant 100 mg once daily in combination with escitalopram 10 mg once daily in patient...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Finland
DepressionHistorical research record
Countries
France, Finland, Sweden
Sponsor
sanofi-aventis recherche & développement
Drug study icon
CompletedEUCTR 2008-001718-26

An eight-week, multicenter, randomized, double-blind, placebo-controlled dose-finding study, with escitalopram (10mg daily) as active control, to evaluate the efficacy, safety and tolerability of t...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Slovakia
DepressionHistorical research record
Countries
Slovakia
Sponsor
Sanofi-Aventis Recherche & Développement
Drug study icon
CompletedEUCTR 2014-000230-34

An interventional, randomised, double-blind, parallel-group, placebo-controlled, active-referenced (paroxetine), fixed-dose study on the efficacy of vortioxetine on cognitive dysfunction in working...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Estonia
DepressionHistorical research record
Countries
Estonia, Finland, Germany, + 2 others
Sponsor
H. Lundbeck A/S
Drug study icon
CompletedEUCTR 2017-004030-28

Cognition and weight gain during antidepressant treatment.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Denmark
DepressionHistorical research record
Countries
Denmark
Sponsor
Psychiatric Research Unit
Drug study icon
CompletedEUCTR 2005-002388-95

Efficacy of agomelatine (25 to 50 mg/day) given orally on quality of remission in elderly depressed patients, after a 12-week treatment period.A randomised, double-blind, flexible-dose internationa...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
DepressionHistorical research record
Countries
Belgium, Denmark, Hungary, + 3 others
Sponsor
Institut de Recherches Internationales Servier [...] 1. Institut de Recherches Internationales Servier 2. Laboratorios Servier S.L. (For Spain only)
Drug study icon
CompletedEUCTR 2013-003370-27

Functional MRI (fMRI) after challenge and treatment with antidepressants and their relation to the clinical course, to the Hypothalamus-Hypophysis-Adrenocortical Axis and the colon microbiome

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
DepressionHistorical research record
Countries
Germany
Sponsor
Rainer Rupprecht, Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg am Bezirksklinikum

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.